Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...

Radiotherapy professionals from 10 Asian countries have completed an IAEA training course on ultra-hypofractionated radiotherapy — a way of treating cancer with ionizing radiation that reduces ...

IAEA radiation oncologist Soha Salem leading a session on ultra-hypofractionated radiotherapy during a regional training course held in Malaysia in ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

Co-locating Convergent's manufacturing at NorthStar establishes an integrated and reliable supply chain for CONV01-<ALPHA> drug product production with Ac-225, relieving supply constraints for ...